Data / Form D filings / Notable Labs, Inc.
Notable Labs, Inc.: Form D filings
Notable Labs, Inc., a biotechnology company in Foster City, CA, filed 6 Form D notices with the SEC between 2016 and 2023. The latest, on March 8, 2023, reports $10.3 million sold of a $10.3 million offering to 26 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 320 HATCH DRIVE, Foster City, CA, 94404
- Phone
- (415) 851-2410
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1674834
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | New notice | $10,336,259 | $10,336,259 | 26 | Feb 21, 2023 | sec.gov | |
| Jul 15, 2022 | New notice | $10,500,000 | $10,063,252 | $436,748 | 19 | Jun 30, 2022 | sec.gov |
| Dec 13, 2019 | New notice | $43,997,297 | $39,757,561 | $4,239,736 | 37 | Jun 28, 2019 | sec.gov |
| Aug 31, 2017 | New notice | $17,723,732 | $14,840,492 | $2,883,240 | 95 | Aug 16, 2017 | sec.gov |
| Mar 16, 2017 | New notice | $2,715,000 | $2,715,000 | 23 | May 19, 2016 | sec.gov | |
| May 17, 2016 | New notice | $4,488,500 | $4,488,500 | 40 | Jul 30, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph Wagner | Executive Officer | |
| Matthew De Silva | Director | |
| Adam Seabrook | Director | |
| James Kim | Director | |
| Thomas Bock | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 6, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Notable Labs, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.